As of January 2023, there are 521 artificial intelligence (AI) medical devices on the market in the US and most are imaging devices.
While the FDA first approved a clinical AI algorithm in 1995, the growth rate has been slow until recent years....
Report Finds Most FDA-Approved AI Devices Are Used For Imaging
The pace of artificial intelligence development has accelerated in recent years and now most of the artificial intelligence devices approved by the FDA are imaging devices.
More from Regulation
• By
To succeed in medtech, investors must focus on patient outcomes. Gilde Healthcare says involving patients boosts product effectiveness, access and market success — making it a smart strategy in today’s strained healthcare systems.
• By
MedTech Europe is ready to become involved and shape Europe’s Life Sciences Strategy and help drive regulatory simplification from the top to make the EU “the world’s most attractive place for life sciences by 2030.”
• By
The US FDA has issued an updated final guidance document on cybersecurity considerations for medical device manufacturers that replaces a previous final guidance the agency issued in 2023.
• By
Amendment brings new benefits for device accessories and aesthetic devices used by healthcare professionals.
More from Policy & Regulation
• By
Two recent recalls from the US FDA involve three deaths linked to an issue with an Abiomed heart pump — as well as three serious injuries related to angiographic catheters from Cook Medical.
• By
Dexcom’s CEO Kevin Sayer discusses this fall’s planned launch of the 15-day G7 CGM, downplays Abbott’s dual-sensor while focusing on development of multi-analyte G8, making OTC Stelo app more “consumerish” for Europeans, and more.
• By
The rate at which new documents to support the implementation of EU medtech regulations are issued has slowed of late; but June bucked the trend, with a flurry of activity.